Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

The Complete Library

All Research Guides

Browse every published guide in the Researcher's Field Guide, including the complete research journey and supplemental collections, listed alphabetically for quick reference.

Complete Library

Every published guide

Showing 3,001–3,050 of 5,065 guides

5,065 guides
PART 04 · SUBPART 14 · GUIDE 183

When to Use a Crossover Trial

When Is a Crossover Trial Appropriate?

A crossover trial allows participants to receive multiple interventions in a planned sequence, often improving the precision of treatment comparisons. Learn when this design is appropriate, which assumptions must hold, and how to decide whether a parallel-group trial would provide more defensible evidence.

PART 04 · SUBPART 14 · GUIDE 182

Counterbalancing in Experimental Design

What Is Counterbalancing, and When Is It Needed?

Counterbalancing distributes experimental conditions across different presentation orders to reduce systematic confounding between treatment and position. Learn when it is necessary, how common arrangements work, and what limitations researchers must consider.

PART 04 · SUBPART 14 · GUIDE 181

Order Effects in Experimental Design

What Are Order Effects, and How Should Researchers Address Them?

Order effects occur when the sequence or position of experimental conditions influences participants' responses. Learn how to recognize different order effects, choose appropriate design safeguards, and interpret results without confusing treatment effects with sequence-related changes.

PART 04 · SUBPART 14 · GUIDE 179

When Within-Subjects Designs Are Inappropriate

When Is a Within-Subjects Design Inappropriate?

Within-subjects designs are not appropriate for every experimental comparison. Learn when repeated exposure compromises validity, why counterbalancing may be insufficient, and how to choose a defensible alternative.

PART 04 · SUBPART 14 · GUIDE 178

Within-Subjects Design Efficiency

When Is a Within-Subjects Design More Efficient?

Within-subjects designs can improve statistical efficiency by comparing participants with themselves, reducing the influence of stable individual differences. Learn when these gains are meaningful, how to evaluate them, and when practical limitations outweigh the benefits.

PART 04 · SUBPART 14 · GUIDE 177

Between-Subjects vs. Within-Subjects Designs

Between-Subjects vs. Within-Subjects Designs: Which Comparison Makes More Sense?

Between-subjects designs compare different participants across conditions, while within-subjects designs compare conditions within the same participants. The better choice depends on what is being studied and whether experiencing one condition can influence another.

PART 04 · SUBPART 13 · GUIDE 176

Ethical Alternatives to Control Groups

What Should Researchers Do When the Ideal Control Group Would Be Unethical?

When an ideal scientific comparison would require withholding beneficial treatment or essential support, researchers must reconsider the design. Learn how to preserve meaningful causal comparisons while protecting participants through active controls, add-on interventions, and other ethically defensible approaches.

PART 04 · SUBPART 13 · GUIDE 175

When Multiple Control Groups Become Unnecessary

When Do Multiple Control Groups Create Unnecessary Research Complexity?

Additional control groups can clarify treatment effects, but they can also complicate recruitment, weaken individual comparisons, and introduce unnecessary analytical and ethical burdens. Learn how to recognize when another control group adds little scientific value.

PART 04 · SUBPART 13 · GUIDE 174

When to Add a Second Comparison Group

When Should You Add a Second Comparison Group to a Study?

A second comparison group can answer an additional research question, distinguish intervention-specific effects, or strengthen the interpretation of existing comparisons. Learn when the extra group is justified and when it adds complexity without improving the evidence.

PART 04 · SUBPART 13 · GUIDE 173

When Comparison Groups Are Too Similar

Can a Comparison Group Be Too Similar to Detect a Meaningful Effect?

A comparison group can be appropriately matched to the intervention group yet receive an intervention so similar that the study cannot isolate the effect of interest. Learn how treatment overlap, contamination, and insufficient differentiation affect interpretation, and when a small effect is still meaningful.

PART 04 · SUBPART 13 · GUIDE 172

When Comparison Groups Are Too Different

Can a Comparison Group Be Too Different to Provide a Valid Comparison?

A comparison group can be so different from the intervention group that the resulting contrast becomes misleading. Learn which differences matter, how to assess comparability, and when matching or statistical adjustment cannot rescue an unsuitable comparison.

PART 04 · SUBPART 13 · GUIDE 171

Participants as Their Own Controls

Can Participants Serve as Their Own Controls in a Research Study?

Participants can sometimes serve as their own controls, allowing researchers to compare outcomes within the same individuals. Learn when this approach is appropriate, what it controls for, and why time-related changes, carryover effects, and measurement decisions still matter.

PART 04 · SUBPART 13 · GUIDE 170

When to Use External Controls

When Is an External Control Group Acceptable in Research?

External controls can provide a comparison when an internally randomized control group is unavailable, but their validity depends on more than finding a similar dataset. Learn how to assess external-control suitability, align eligibility and follow-up, address confounding, and determine when the evidence is sufficiently credible.

PART 04 · SUBPART 13 · GUIDE 169

When to Use Historical Controls

When Is a Historical Control Group Acceptable in Research?

Historical controls allow researchers to compare a current intervention group with participants treated or observed in the past. Understand when this approach is defensible, how temporal differences threaten validity, and what evidence is needed to support a credible comparison.

PART 04 · SUBPART 13 · GUIDE 168

Standard of Care for Control Groups

Should Control Groups Receive the Current Standard of Care?

Control groups generally should not be denied established effective care merely to simplify a trial. Learn how to identify an appropriate standard-of-care comparator, understand justified exceptions, and distinguish ethical obligations from routine clinical practice.

PART 04 · SUBPART 13 · GUIDE 166

What Makes a Comparison Group Appropriate?

What Makes a Comparison Group Appropriate?

An appropriate comparison group is not simply a group that looks similar to the intervention group. It must represent the alternative required by the research question and support a credible interpretation of the resulting contrast.

PART 04 · SUBPART 13 · GUIDE 165

Control Group vs. Comparison Group

Control Group vs. Comparison Group: What’s the Difference?

Control group and comparison group are sometimes used interchangeably, but not always. The more important issue is what the group represents, how it was formed, and whether it provides the comparison your research question requires.

PART 04 · SUBPART 12 · GUIDE 163

Randomization Integrity in Small Studies

How Do You Preserve Randomization Integrity in a Small Study?

Small randomized trials are particularly vulnerable to chance imbalance, predictable allocation, and imprecise treatment estimates. Learn how to protect the randomization process, select appropriate allocation methods, and distinguish genuine design failures from the expected consequences of small samples.

PART 04 · SUBPART 12 · GUIDE 162

Participant Enrollment and Intervention Assignment

Who Should Enroll Participants and Assign Interventions in a Randomized Study?

Who should confirm eligibility, enroll participants, and release treatment assignments in a randomized controlled trial? Learn how to allocate responsibilities, prevent foreknowledge of treatment assignment, and document a secure, reproducible enrollment process.

PART 04 · SUBPART 12 · GUIDE 161

Who Generates the Randomization Sequence?

Who Should Generate the Randomization Sequence in a Research Study?

Who should create the randomization sequence in a controlled trial? Learn why an independent statistician or authorized allocation specialist is often preferable, how responsibilities should be separated, and what smaller research teams can do to protect assignment integrity.

PART 04 · SUBPART 12 · GUIDE 160

Predictable Randomization Assignments

Can Researchers Predict the Next Assignment in a Poorly Concealed Randomization Scheme?

A randomization sequence can be generated correctly yet become predictable during recruitment. Learn how fixed blocks, exposed allocation lists, and inadequate concealment allow researchers to anticipate assignments, why this threatens causal inference, and how to protect the randomization process.

PART 04 · SUBPART 12 · GUIDE 159

Rerandomization and Baseline Imbalance

Should You Rerandomize if Treatment Groups Are Imbalanced at Baseline?

A baseline imbalance does not automatically justify repeating randomization. Learn why informal rerandomization can undermine trial integrity, how prespecified rerandomization differs, and which methods can address prognostic differences without manipulating assignments.

PART 04 · SUBPART 12 · GUIDE 158

Baseline Imbalance After Randomization

Why Can Proper Randomization Still Produce Baseline Imbalance Between Groups?

Random assignment does not guarantee identical treatment groups. Understand why baseline imbalance can occur after proper randomization, how to investigate suspicious differences, and why prespecified covariate adjustment is usually more defensible than testing or correcting baseline differences after allocation.

PART 04 · SUBPART 12 · GUIDE 157

Allocation Concealment vs. Blinding

What Is Allocation Concealment, and How Is It Different From Blinding?

Allocation concealment and blinding protect randomized trials against different sources of bias. Learn when each operates, who should remain unaware of treatment assignments, and how to implement secure allocation even when blinding is impossible.

PART 04 · SUBPART 12 · GUIDE 156

How Many Stratification Variables?

How Many Stratification Variables Are Too Many in Randomization?

Adding stratification variables may improve balance on important prognostic factors, but too many can create sparse strata and complicated allocation procedures. Learn how to evaluate the number of variables your trial can support and when alternative methods may be more appropriate.

PART 04 · SUBPART 12 · GUIDE 155

When to Use Stratified Randomization

When Should You Use Stratified Randomization in Research?

Stratified randomization can improve treatment allocation balance on important baseline characteristics, but it is not necessary for every RCT. Learn when stratification is worthwhile, which variables to select, how to avoid excessive strata, and why the analysis should reflect the randomization design.

PART 04 · SUBPART 12 · GUIDE 154

Simple vs. Block vs. Stratified Randomization

Simple vs. Block vs. Stratified Randomization: Which Should You Use?

Simple, block, and stratified randomization solve different allocation problems. Learn how each method works, how blocking and stratification can be combined, and which approach best fits your trial's sample size, prognostic variables, recruitment process, and allocation-concealment requirements.

PART 04 · SUBPART 12 · GUIDE 153

What Random Assignment Actually Does

What Does Random Assignment Actually Do, and What Doesn’t It Do?

Random assignment strengthens causal inference by using chance rather than choice to allocate study conditions. It does not guarantee identical groups, representative samples, perfect implementation, or an unbiased study by itself.

PART 04 · SUBPART 12 · GUIDE 152

Randomization vs. Random Sampling

Randomization vs. Random Sampling: Why Do Researchers Keep Confusing Them?

Random sampling determines who enters your sample. Random assignment determines which study condition sampled or recruited participants enter. They solve different methodological problems and support different kinds of inference.

PART 04 · SUBPART 11 · GUIDE 151

Internal Validity vs. Real-World Relevance

How Do You Balance Internal Validity and Real-World Relevance in an RCT?

A randomized trial can produce a credible causal estimate yet provide limited guidance for routine practice. Learn how to protect internal validity while designing recruitment, interventions, comparisons, and outcomes that make RCT findings relevant to real-world decisions.

PART 04 · SUBPART 11 · GUIDE 150

Pragmatic Randomized Controlled Trials

Can a Randomized Controlled Trial Also Be Pragmatic?

A randomized controlled trial can be pragmatic without abandoning experimental rigor. Understand how pragmatic trials combine random assignment with routine practice, what makes a trial more or less pragmatic, and how to design a study that produces evidence relevant to real-world decisions.

PART 04 · SUBPART 11 · GUIDE 149

Washout Periods in Randomized Trials

When Does a Clinical Trial Need a Washout Period?

A washout period may be necessary when residual effects from an earlier treatment could influence subsequent trial outcomes. Learn when washout is justified, how to determine an appropriate interval, and why pharmacological elimination alone may not guarantee that carryover effects have disappeared.

PART 04 · SUBPART 11 · GUIDE 148

Run-In Periods in Clinical Trials

When Does a Clinical Trial Need a Run-In Period?

A run-in period can help researchers assess adherence, stabilize treatment, or establish eligibility before randomization. Learn when it is justified, how it differs from screening and washout, and why excluding participants during run-in can change the population to which trial findings apply.

PART 04 · SUBPART 11 · GUIDE 147

When to Pilot an RCT

When Does a Randomized Controlled Trial Need a Pilot Phase?

Not every randomized controlled trial needs a separate pilot study. Learn when unresolved questions about recruitment, intervention delivery, retention, measurement, or trial procedures justify piloting, and how to decide whether the definitive trial should proceed.

PART 04 · SUBPART 11 · GUIDE 146

Multiple Primary Questions in RCTs

Can a Randomized Controlled Trial Answer More Than One Primary Research Question?

A randomized controlled trial can address more than one primary research question, but doing so changes its statistical and interpretive obligations. Learn how to distinguish multiple outcomes from multiple treatment comparisons, control false-positive claims, and determine whether the trial can support every primary objective.

PART 04 · SUBPART 11 · GUIDE 144

Two-Arm vs. Multi-Arm Trials

Should You Use a Two-Arm or Multi-Arm Randomized Controlled Trial?

Should your randomized controlled trial compare one intervention with one control, or evaluate several interventions simultaneously? Understand when two-arm and multi-arm designs are appropriate, how they differ statistically, and what should determine your choice.

PART 04 · SUBPART 11 · GUIDE 143

Choosing the Number of Trial Arms

How Many Study Arms Should a Randomized Controlled Trial Have?

How many treatment and control groups does a randomized controlled trial actually need? Learn how to determine the appropriate number of study arms without compromising statistical power, interpretability, or recruitment feasibility.

PART 04 · SUBPART 11 · GUIDE 142

Choosing the Unit of Randomization

Should You Randomize Individuals, Groups, Sites, or Time Periods in an RCT?

Should an RCT assign treatments to individual participants, entire groups, institutions, or time periods? Learn how to select the appropriate unit of randomization while accounting for intervention delivery, contamination, statistical efficiency, and practical constraints.

PART 04 · SUBPART 11 · GUIDE 141

What to Randomize in a Trial

What Exactly Should Be Randomized in a Randomized Controlled Trial?

Randomization does not always mean assigning individual participants to treatment groups. Learn how to identify the correct unit of randomization, distinguish assignment from measurement and analysis, and avoid allocation decisions that undermine a controlled trial.

PART 04 · SUBPART 11 · GUIDE 140

When RCTs Are Inappropriate

When Is a Randomized Controlled Trial Infeasible or Inappropriate?

Randomized controlled trials can provide strong causal evidence, but randomization may be impossible, unethical, or unsuitable for certain interventions. Understand the reasons, distinguish genuine constraints from convenience, and identify defensible alternative designs.

PART 04 · SUBPART 11 · GUIDE 139

When RCTs Are Unnecessary

When Is a Randomized Controlled Trial Unnecessary?

Randomized controlled trials are valuable for estimating intervention effects, but not every research question requires randomization. Understand when an RCT adds little useful evidence, which alternative designs may be appropriate, and how to justify your methodological choice.

PART 04 · SUBPART 11 · GUIDE 138

When to Use a Randomized Controlled Trial

When Is a Randomized Controlled Trial the Right Research Design?

A randomized controlled trial can provide strong evidence about an intervention's causal effects, but randomization is not always necessary or appropriate. Learn when an RCT fits your research question, which conditions make it feasible, and what its limitations mean for your design.

PART 04 · SUBPART 10 · GUIDE 137

Interrupted Time Series vs. Before-and-After

When Is an Interrupted Time-Series Design Stronger Than a Simple Before-and-After Study?

An interrupted time-series design can provide stronger evidence than a simple before-and-after comparison by examining whether an intervention changes an existing outcome trajectory. Learn when this design is appropriate, how it works, and which assumptions determine the credibility of its conclusions.

PART 04 · SUBPART 10 · GUIDE 136

Regression to the Mean

What Is Regression to the Mean, and Why Can It Mislead Before-and-After Studies?

Participants selected because of unusually high or low scores may appear to improve or deteriorate even without an effective intervention. Learn how regression to the mean occurs, why it threatens before-and-after studies, and how to reduce misleading interpretations.

PART 04 · SUBPART 10 · GUIDE 135

Immediate vs. Long-Term Outcomes

Should You Measure Long-Term Outcomes as Well as Immediate Outcomes?

An intervention may produce immediate improvement without lasting benefits, or its effects may emerge only after time has passed. Learn when measuring both immediate and long-term outcomes is necessary and how to interpret differences between them.

PART 04 · SUBPART 10 · GUIDE 134

Timing Post-Intervention Measurements

How Soon After an Intervention Should Outcomes Be Measured?

Measuring outcomes too early may miss an intervention's effects, while measuring too late can introduce competing explanations. Learn how to select post-intervention assessment times that match the outcome, intervention mechanism, and research question.